Oxford BioTherapeutics is a biotechnology

Oxford BioTherapeutics is a biotechnology company focused on developing next-generation oncology treatments through targeted therapies, including antibody-drug conjugates (ADCs), immuno-oncology, T-cell engagers (TCEs), and radiopharmaceuticals.

The goal was to create a restrained, professional digital experience built around stakeholder-focused content and visually clear scientific communication. The hero illustration depicts a T cell activating after detecting a tumor cell, reflecting the company’s work on redefining the cancer–immune synapse and exploring novel immune checkpoint mechanisms.